Omega Healthcare InvestorsOHI
- Legal name
- Omega Healthcare Investors, Inc.
- Sector
- Financial Services
- Industry
- Real Estate Investment Trusts
- Exchange
- NYSE
Stock Price $OHI
Latest filings
You are here#24 of 27 in Real Estate by market cap
Area = market cap · hover a tile to read it
OHI filed 12 annual reports (10-K), 34 quarterly reports (10-Q) and 126 current reports (8-K) between 2016 and 2026.
- 8-K · Jan 8, 2016
- 8-K · Feb 3, 2016
- 8-K · Feb 10, 2016
- 10-K · Feb 29, 2016
- 8-K · Mar 23, 2016
- 8-K · May 4, 2016
- 10-Q · May 6, 2016
- 8-K · Jun 13, 2016
- 8-K · Jun 30, 2016
- 8-K · Jul 5, 2016
- 8-K · Jul 12, 2016
- 8-K · Aug 2, 2016
- 10-Q · Aug 5, 2016
- 8-K · Oct 31, 2016
- 10-Q · Nov 8, 2016
- 8-K · Jan 13, 2017
- 8-K · Feb 8, 2017
- 10-K · Feb 24, 2017
- 8-K · Mar 29, 2017
- 8-K · Apr 4, 2017
- 8-K · May 3, 2017
- 10-Q · May 5, 2017
- 8-K · May 31, 2017
- 8-K · Jun 9, 2017
- 8-K · Jul 26, 2017
- 10-Q · Aug 9, 2017
- 10-Q/A · Aug 9, 2017
- 10-K/A · Aug 9, 2017
- 8-K · Oct 30, 2017
- 10-Q · Nov 7, 2017
- 8-K · Dec 22, 2017
- 8-K · Feb 13, 2018
- 10-K · Feb 23, 2018
- 8-K · May 1, 2018
- 8-K · May 7, 2018
- 10-Q · May 10, 2018
- 8-K · Jun 11, 2018
- 8-K · Aug 3, 2018
- 10-Q · Aug 8, 2018
- 8-K · Sep 7, 2018
- 8-K · Oct 25, 2018
- 8-K · Nov 2, 2018
- 8-K · Nov 5, 2018
- 10-Q · Nov 7, 2018
- 8-K · Dec 20, 2018
- 8-K · Jan 4, 2019
- 8-K · Feb 6, 2019
- 8-K · Feb 11, 2019
- 10-K · Feb 26, 2019
- 8-K · May 7, 2019
- 10-Q · May 9, 2019
- 8-K · May 17, 2019
- 8-K · Jun 11, 2019
- 8-K · Aug 6, 2019
- 10-Q · Aug 8, 2019
- 8-K · Sep 12, 2019
- 8-K · Sep 20, 2019
- 8-K · Nov 5, 2019
- 10-Q · Nov 8, 2019
- 8-K · Dec 20, 2019
- 8-K · Jan 2, 2020
- 8-K · Feb 5, 2020
- 10-K · Feb 28, 2020
- 8-K · Mar 25, 2020
- 8-K · Mar 31, 2020
- 8-K · May 4, 2020
- 10-Q · May 8, 2020
- 8-K · Jun 11, 2020
- 8-K · Jul 14, 2020
- 8-K · Aug 5, 2020
- 10-Q · Aug 7, 2020
- 8-K · Sep 24, 2020
- 8-K · Oct 9, 2020
- 8-K · Oct 23, 2020
- 8-K · Oct 29, 2020
- 10-Q · Nov 3, 2020
- 8-K · Jan 6, 2021
- 8-K · Feb 4, 2021
- 10-K · Feb 22, 2021
- 8-K · Mar 3, 2021
- 8-K · Mar 4, 2021
- 8-K · Mar 4, 2021
- 8-K · Mar 10, 2021
- 8-K · Mar 18, 2021
- 8-K · Apr 14, 2021
- 8-K · May 3, 2021
- 8-K · May 4, 2021
- 10-Q · May 4, 2021
- 8-K · May 20, 2021
- 8-K · Jun 3, 2021
- 8-K · Jun 8, 2021
- 8-K · Aug 2, 2021
- 8-K · Aug 2, 2021
- 10-Q · Aug 3, 2021
- 8-K · Aug 5, 2021
- 8-K · Sep 21, 2021
- 8-K · Nov 4, 2021
- 10-Q · Nov 5, 2021
- 8-K · Jan 4, 2022
- 8-K · Jan 27, 2022
- 8-K · Feb 2, 2022
- 10-K · Feb 17, 2022
- 8-K · Apr 4, 2022
- 8-K · May 2, 2022
- 10-Q · May 3, 2022
- 8-K · Jun 6, 2022
- 8-K · Aug 1, 2022
- 10-Q · Aug 2, 2022
- 8-K · Oct 21, 2022
- 8-K · Nov 2, 2022
- 10-Q · Nov 3, 2022
- 8-K · Jan 3, 2023
- 8-K · Jan 9, 2023
- 8-K · Feb 2, 2023
- 10-K · Feb 14, 2023
- 8-K · May 2, 2023
- 10-Q · May 3, 2023
- 8-K · Jun 5, 2023
- 8-K · Aug 2, 2023
- 10-Q · Aug 3, 2023
- 8-K · Aug 11, 2023
- 8-K · Nov 2, 2023
- 10-Q · Nov 3, 2023
- 8-K · Dec 4, 2023
- 8-K · Jan 2, 2024
- 8-K · Feb 7, 2024
- 10-K · Feb 12, 2024
- 8-K · Mar 12, 2024
- 8-K · Mar 14, 2024
- 8-K · Apr 15, 2024
- 8-K · May 2, 2024
- 10-Q · May 3, 2024
- 8-K · Jun 3, 2024
- 8-K · Jun 7, 2024
- 8-K · Aug 1, 2024
- 10-Q · Aug 2, 2024
- 8-K · Sep 6, 2024
- 8-K · Oct 30, 2024
- 10-Q · Oct 31, 2024
- 8-K · Jan 6, 2025
- 8-K · Feb 5, 2025
- 10-K · Feb 13, 2025
- 8-K · May 1, 2025
- 10-Q · May 2, 2025
- 8-K · May 12, 2025
- 8-K · Jun 2, 2025
- 8-K · Jun 6, 2025
- 8-K · Jun 6, 2025
- 8-K · Jun 11, 2025
- 8-K · Jun 20, 2025
- 8-K · Jul 10, 2025
- 8-K · Jul 31, 2025
- 10-Q · Aug 1, 2025
- 8-K · Sep 15, 2025
- 8-K · Oct 1, 2025
- 8-K · Oct 15, 2025
- 8-K · Oct 30, 2025
- 10-Q · Oct 31, 2025
- 8-K · Nov 3, 2025
- 8-K · Jan 7, 2026
- 8-K · Feb 4, 2026
- 10-K · Feb 9, 2026
- 8-K · Apr 28, 2026
- 10-Q · Apr 29, 2026
- 8-K · May 21, 2026
- 8-K · Jun 5, 2026
- 8-K · Jul 29, 2026
- 10-Q · Jul 30, 2026
- 8-K · Oct 1, 2026
- 8-K · Oct 5, 2026
- 8-K · Nov 3, 2026
- 10-Q · Nov 4, 2026
01—Key figures
Revenue Trend
Year-over-year comparison from 10-K annual reports · Dashed line: constant growth FY2020–FY2025
- $1.19B
Latest bar from 10-KFY2025Click a bar to open its SEC filingTap a bar to open its SEC filing
View full history →All OHI Financial Metrics46 metrics
Income Statement13
Balance Sheet14
Cash Flow14
02—Overview
Omega Healthcare Investors Financial Overview 2021–2025
Updated Nov 5, 2026Nareit FFO nearly doubled in three years, from $460.5 million in FY2022 to $898.9 milliona in FY2025, while Omega Healthcare Investors held its dividend flat at $2.68 per share. That is the core thesis: a landlord that spent 2021 and 2022 absorbing operator failures has rebuilt its cash earnings and cut leverage, but the credit risk behind that recovery has not gone away.
Revenue grew from $1.06 billion in FY2021 to $1.19 billionb in FY2025, with a trough of $878.2 million in FY2022. Net income reached $609.5 million in FY2025, up from $417.8 million in FY2024. Total debt fell from $5.3 billion to $4.3 billion, or 44.1% of total capitalization. Operators on a cash basis of revenue recognition shrank from 36.5% of revenue in FY2022 to 19.0% in FY2025. The caveats are real. Twenty operator leases still sit on a cash basis, Genesis Healthcare is in Chapter 11, and year-end cash dropped to $27.0 million from $518.3 million. A $1.8 billion revolver cushions that.
The market priced the recovery at $44.34c per share at the close of FY2025 (December 30, 2025). That was 22.9x earnings and a $13.1 billion market cap. Comparable prices for earlier year-ends aren't in the data, so the multiple's trend can't be judged here.
Recent Developments (Q2 and Q3 2026)
Omega reshaped its portfolio in Q2 and Q3 2026. It sold 26 facilities for $562.6 milliond in Q2, then moved 32 Florida nursing homes to PACS Group on October 1. That adds $26.1 million of first-year rent after a $90 million termination fee. Adjusted FFO rose to $262 million in Q3 from $243 million, and 2026 guidance moved to $3.28 to $3.30 per share. Revenue reached $340.6 million versus $311.6 million, but net income fell to $86.8 million from $185.0 million on $59.9 million of U.K. acquisition costs. Matthew Gourmand became CEO on October 1, and Neal Ballew became CFO. The Genesis sale closed, returning $149.5 million.
Bull case: rent is rising, the revolver balance is zero, and guidance has been raised twice. Bear case: at 25.3x earnings as of November 3, 2026, the stock leaves little margin, while 22 operators remain on a cash basis and Maplewood's $263.6 millione revolver is on non-accrual.
What to watch: integration of the £631.7 million Runwood loan and U.K. operators; the $700.0 million note maturity due April 2027
03—Filings
Recent SEC Filings
- 8-KOmega Healthcare Investors 8-K Report, Financial Results (Nov 3, 2026)Omega Healthcare Investors, Inc. ("Omega") furnished a press release on November 3, 2026 reporting third quarter 2026 results. Net income was $87 million, or $0.27 per diluted share, versus $0.60 per basic share... more precisely, net income available to common stockholders was $83.1 million, or $0.27 per diluted share, for the quarter. AFFO was $262 million, or $0.82 per diluted share, compared with $243 million, or $0.79 per diluted share, in the third quarter of 2025. FAD was $250 million, or $0.78 per diluted share, versus $231 million, or $0.75 per diluted share, a year earlier. NOI rose to $332 million from $310 million. Investment activity was active. Omega completed $182 million of investments in the third quarter and $946 million since quarter-end, bringing 2026 year-to-date investment activity to approximately $1.5 billion. The largest post-quarter transaction was an $846 million U.K. mortgage loan to an affiliate of Foundation Partners Asset Management Limited, secured by 48 U.K. care homes and leasehold interests in 7 additional care homes, bearing interest at 8.72%. In October, Omega transitioned 32 Florida skilled nursing facilities to PACS Group, Inc. for a $90 million termination fee paid to the prior operator, adding $26.1 million of initial annual contractual rent. The Genesis Healthcare bankruptcy sale was finalized in October, with Omega's lease assumed by NewGen and $149.5 million received in repayment of DIP and term loans. Management raised its 2026 AFFO per diluted share guidance to $3.28 to $3.30, from $3.22 to $3.26, and declared a quarterly dividend of $0.68 per share payable November 16, 2026. As of September 30, 2026, total indebtedness was $4.1 billion at a weighted average interest rate of 4.2%, cash and cash equivalents were $195.9 million, and $2.0 billion was undrawn under the unsecured revolving credit facility. CEO Matthew Gourmand said leverage had been reduced to the lowest level in the Company's history.
- 8-KOmega Healthcare Investors 8-K Report, Regulation FD Disclosure (Oct 5, 2026)Omega Healthcare Investors, Inc. (NYSE: OHI) furnished an 8-K on October 5, 2026, under Item 7.01 (Regulation FD Disclosure), attaching a press release announcing a portfolio transition. According to the press release, Omega transitioned 32 skilled nursing facilities in Florida from an operator managed by affiliates of Airamid Health Services, LLC to subsidiaries of PACS Group, Inc. (NYSE: PACS), with an effective date of October 1, 2026. The information is furnished rather than filed and is not deemed incorporated by reference into other Company filings. The filing states that rent on this portfolio is scheduled to increase by $26.1 million in year one and by an additional $2.5 million in year two, with contractual 2% escalators thereafter. The portfolio will be added to Omega's existing master lease with PACS. Omega also incurred a one-time expense of approximately $90 million in connection with the transition. Management characterized the transaction as highly accretive for shareholders. CEO Matthew Gourmand described it as an example of Omega's active portfolio management, and CIO Vikas Gupta noted a relationship of over 15 years with Airamid and an intention to grow the relationship with PACS. The press release also includes standard forward-looking statement cautions.
- 8-KOmega Healthcare Investors 8-K Report, Executive Changes (Oct 1, 2026)Omega Healthcare Investors, Inc. (OHI) filed this Current Report on Form 8-K dated October 1, 2026, to disclose a leadership transition under Item 5.02. Effective October 1, 2026, the Board of Directors appointed Matthew P. Gourmand, the Company's President, as President and Chief Executive Officer, succeeding C. Taylor Pickett, who is retiring as CEO. The filing states that Mr. Pickett's retirement is not the result of any disagreement with the Company on its operations, policies or practices. The Board also appointed Mr. Gourmand as a director, filling the vacancy left by Mr. Pickett's retirement from the Board for the remainder of Mr. Pickett's term expiring in 2027. The number of directors on the Board remains at eight. The Board does not currently expect to appoint Mr. Gourmand to any committees. Mr. Gourmand, age 51, has been President since January 1, 2025, and previously served as Senior Vice President of Corporate Strategy & Investor Relations from January 2021 and as Senior Vice President of Investor Relations from October 2017. Before joining the Company, he worked as an equity portfolio manager, an equity research analyst, and in the audit department of Deloitte. The filing states he will receive no separate director compensation beyond what is provided under his employment agreement, and it discloses no related party transactions or family relationships requiring disclosure.
- 8-KOmega Healthcare Investors 8-K Report, Financial Results (Jul 29, 2026)Omega Healthcare Investors, Inc. (NYSE: OHI) reported second quarter 2026 results on July 29, 2026. Net income was $380 million, or $1.19 per diluted share, compared with $140 million, or $0.46 per diluted share, in Q2 2025. The quarter was lifted by a $246.5 million gain on assets sold, which accompanied the sale of 26 facilities for $562.6 million. Adjusted FFO was $261 million, or $0.83 per diluted share, compared with $232 million, or $0.77 per diluted share, a year earlier. FAD was $248 million, or $0.78 per diluted share, and NOI was $331 million, compared with $281 million in Q2 2025. Management stated that FAD per share rose 6.3% year over year. Omega completed $126 million of new investments in Q2 2026, mainly $110 million of real estate acquisitions and $16 million of real estate loan fundings, and completed another $93 million in July 2026. Management said the pipeline supports a significant increase in capital deployment through the rest of 2026 and into early 2027, although it does not provide specific acquisition guidance. The company also said it had transitioned 20 Ciena-operated Laurels skilled nursing facilities to new operators and the Saber PropCo JV, and that it holds a 9.9% equity interest in Saber. The board raised the quarterly common dividend by $0.01 to $0.68 per share, payable August 14, 2026, and the 2026 Adjusted FFO guidance range was increased to $3.22 to $3.26 per diluted share from $3.19 to $3.25. As of June 30, 2026, the company had $4.1 billion of outstanding indebtedness at a weighted average interest rate of 4.2%, cash of $39.0 million, and $2.0 billion of undrawn revolver capacity. The company also reported that Genesis, which filed for Chapter 11 in July 2025, has continued to make required contractual rent and interest payments through July 2026.
- 8-KOmega Healthcare Investors 8-K Report, Shareholder Vote Results (Jun 5, 2026)Omega Healthcare Investors, Inc. held its 2026 Annual Meeting of Stockholders on June 5, 2026, with holders of 255,926,290 common shares present in person or by proxy, representing approximately 85.93% of total outstanding common stock as of the record date. All three proposals passed: all eight director nominees (Kapila K. Anand, Craig R. Callen, Dr. Lisa C. Egbuonu-Davis, Barbara B. Hill, Kevin J. Jacobs, C. Taylor Pickett, Stephen D. Plavin and Burke W. Whitman) were elected, Ernst & Young LLP was ratified as independent registered public accounting firm for the year ending December 31, 2026 (240,521,117 for versus 14,949,017 against), and executive compensation was approved on an advisory basis (202,883,780 for versus 10,248,851 against). Under Item 8.01, the company updated its beneficial ownership disclosure for holders of more than 5% of its common stock. The filing explains that The Vanguard Group filed an amendment to its Schedule 13G on March 27, 2026, reporting it no longer had or was deemed to have beneficial ownership following an internal corporate realignment, and that two affiliated Vanguard entities subsequently reported beneficial ownership on a disaggregated basis. As of April 8, 2026, the filing lists BlackRock, Inc. with 31,867,200 shares (10.7% of class; 10.1% including common stock equivalents), Vanguard Portfolio Management with 27,160,324 shares (9.1%; 8.6%), and Vanguard Capital Management with 15,689,615 shares (5.3%; 5.0%). The company reported 297,799,835 common shares and 16,284,278 common stock equivalents (including OP Units) outstanding on that date.
04—See also
Related Companies
Annual revenue over each company’s last eight fiscal years, each strip on its own scale from zero.